Codexis, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CDXS | ARCT | RNA | SCTX | 88Q.F | MSLE | |
|---|---|---|---|---|---|---|
| Market cap | 118.27M | 308.96M | 148.48M | 317.67M | 92.91M | 137.27M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.4 | -2.9 | -1.5 | -4.6 | — | -2.5 |
| Price/book | 3.0 | 1.8 | 0.7 | -0.3 | 61.4 | 2.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −49.77% | +10.42% | −40.88% | −14.60% | −26.83% | +8.33% |
| Today | 0.00% | +13.94% | −0.46% | +3.58% | 0.00% | +1.57% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CDXS news ›Codex CLI v0.166 adds codex queue --resume and codex doctor --network-only
Codex CLI v0.166.0 ships six features and seven fixes. Two matter day to day: codex queue --resume and codex doctor --network-only. Both are flags on existing commands, so knowing what each command already does is the quickest way to see…
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head Comparison
Posted by Danessa Lincoln on Oct 19th, 2026 Codexis (NASDAQ:CDXS – Get Free Report) and Revvity (NYSE:RVTY – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the…
Codexis officer proposes $8.62K share sale
The shares came from stock grant vesting and settlement for services rendered. The notice lists Morgan Stanley as broker and an approximate Oct. 12, 2026 sale date. Codexis officer proposes $8.62K share sale The shares are identified as…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net2
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.